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INTRODUCTION

Endoscopic mucosal resection (EMR) is
http://wseed.es/index.php/enlaces/publicaciones/guias-clinicas. This document includes a summary of the guidelines and the recommendations resulting from the consensus meeting.
The purpose of the guidelines is to serve as a reference for Spanish clinicians specializing in digestive endoscopy. The drafting of the guidelines has been a laborious task as it needed to be comprehensive and consensual, and its development has required the collaboration of a large number of professionals. It is likely that some of the content will become obsolete in a short time. For this reason, this document is considered as a starting reference, and an update is planned for 2021. The recommendations are based on the available scientific evidence whenever possible.
Due to the nature of the guidelines, scientific evidence is weak in some areas and, therefore, some recommendations are based on a consensus opinion. Obviously, it is imperative that each physician considers the implementation of these recommendations based on their knowledge and available resources.
INDICATIONS
The cost and complications associated with the treatment of early colorectal neoplasia via open or laparoscopic surgery are significantly higher than those for local treatment.
As most colorectal lesions lack invasive potential, the usual treatment of choice is local as they tend to be curative (3-6).
The indications for EMR are conditioned by the histological characterization, size (an en bloc EMR can be used if the lesion measures less than 20 mm and a fragmented EMR [EMR-f] should be considered when more than 20 mm) and location of the lesion.
Early colorectal neoplasms without a suspected invasive component (non-invasive intraepithelial neoplasia, categories III-IV in the Vienna Classification System) can be managed with local treatment due to the low possibility of loco-regional or distant metastases. It is not necessary to meet the oncological resection criteria in these cases, therefore an en bloc resection of the lesion is not essential. However, when an early neoplastic lesion does have an invasive component that affects the submucosa or other tissue layers, endoscopic resection alone does not allow for the resection of loco-regional adenopathies. Therefore, this is insufficient from an oncological point of view. Unlike the remainder of the gastrointestinal tract, the colon has the peculiarity that its lymphatic vessels lie in deep submucosal planes. This means that invasive colorectal cancers that affect the most superficial submucosal layer (< 1 mm) with histological criteria compatible with a good prognosis (high degree of differentiation
[G1], lack of lymphatic or vascular invasion and no tumor budding) are associated with insignificant rates of nodal involvement. Therefore, these lesions can be treated in the same way as non-invasive lesions. It is preferable to obtain the lesion in a single piece, and thus perform an en bloc resection which enables an adequate histological study of the mass (5-7). (8, 9) .
The correct description of the lesion is the first point that should be taken into account when performing an EMR as the appearance of the lesion is very useful for predicting the presence of invasive cancer (5). This will be explained in detail in the following section and below are the basic definitions:
-NPCRL: A non-pedunculated colorectal lesion is any sessile or flat lesion without a peduncle. According to the Paris classification, this would correspond to type 0-Is and 0-II (see section "Identification and characterization of the lesions").
These lesions account for 13-29% of early neoplasms in the Western hemisphere, with a prevalence similar to that described in Japan. The available scientific evidence regarding neoplastic colorectal lesions is based on the fact that adenomas are considered as precursor lesions of colorectal cancer (CRC).
Nevertheless, it is estimated that 20-30% of CRCs originate from serrated lesions (SL).
Some recent large series have shown that SLs account for up to 16% of all NPCRLs referred for endoscopic treatment. These lesions usually have a smooth and nongranular appearance that could potentially be confused with that of LST-NG lesions.
However, their prognosis is much more favorable and they can be treated with EMR-f despite their large size, as the risk of an invasive neoplasia is minimal. This consideration must be taken into account throughout the document (11) (12) (13) When the position of the lesion makes surgical resection difficult, such as near diverticula, the ileocecal valve, the appendicular orifice or the anal canal, reference centers may be consulted (15) . 
PATIENT REQUIREMENTS AND PREPARATION
Patients should be provided with the necessary information related to their health care in a clear, precise and sufficient manner. A written informed consent must be obtained for invasive diagnostic and therapeutic procedures.
It is advisable to collect diverse data with regard to the patients' medical history prior to performing an EMR, including the following: information about transmissible diseases, serious comorbidities such as hepatopathies, nephropathies or cardiopathies;
anesthesia risk classification (ASA), adverse reactions to drugs, latex or nickel;
consumption of toxic substances, likelihood of pregnancy, time elapsed since the last intake of food and the characteristics of the meal and previous surgeries and endoscopies (16) .
Routine blood tests, electrocardiograms or chest x-rays prior to the EMR is not recommended (17) .
Electrocautery used in EMR could potentially interfere with pacemakers. With regard to newer devices, no specific care is required prior to the EMR. However, the reprogramming of older devices to their asynchronous mode is recommended in patients who depend on the pacemaker and in situations where prolonged electrocautery is expected. Patients with an implantable cardioverter-defibrillator (ICD) device must be advised to consult with a cardiologist specializing in cardiac arrhythmias prior to undergoing the EMR in order to assess the potential deactivation of the tachyarrhythmia detection function of the ICD device and its subsequent reprogramming. Nowadays, the use of magnets by the cardiologist and/or anesthesiologists can prevent a deactivation (18) .
The onset of clinically relevant distant infections secondary to endoscopic procedures is anecdotal. Therefore, the administration of prophylactic antibiotics is not recommended for the prevention of an infectious endocarditis or for patients with an orthopedic prostheses (19) .
Both antiplatelet and anticoagulant therapy increase the risk of immediate and delayed bleeding following an EMR. Therefore, the suspension of anticoagulant treatment prior to the resection of lesions greater than 10 mm is recommended. In patients with a high thromboembolic risk, bridge therapy with low molecular weight heparins can be administered. With regard to ASA, the treatment may be discontinued prior to performing the EMR in patients with a low thrombotic risk. Furthermore, it is recommended that thienopyridines (clopidogrel, prasugrel, ticagrelor, ticlopidine) be suspended 5-7 days prior to the EMR. In cases of double anti-aggregation, the discontinuation of thienopyridines and the maintenance of treatment with ASA is recommended. If this is not possible due to the patient's high thromboembolic risk, the EMR should be delayed until the thienopyridine treatment can be suspended (20, 21) . -Anticoagulation therapy significantly increases the risk of bleeding, therefore it is advisable to suspend such treatment prior to performing an EMR (level of evidence 2+; grade of recommendation C).
-In patients with a high thromboembolic risk, bridge therapy with low molecular weight heparins is recommended (level of evidence 2+; grade of recommendation C).
-An ERM can be carried out in patients receiving acetylsalicylic acid at doses ≤ 300 mg/day. As acetylsalicylic acid seems to increase the risk of bleeding, it could be discontinued prior to the procedure in patients with a low risk of thrombotic events (level of evidence 3; grade of recommendation D).
-As the EMR procedure is associated with a high risk of hemorrhage, it is recommended that thienopyridinines (clopidogrel, prasugrel, ticagrelor and ticlopidina) be discontinued 5-7 days prior to performing an EMR (level of evidence 2+; grade of recommendation C).
-In patients treated with double antiplatelet therapy, it is advised that thienopyridines be discontinued 5-7 days before the procedure and to continue treatment with acetylsalicylic acid at ≤ 300 mg. If the patient has a high thromboembolic risk, the procedure should be delayed until it is safe to discontinue the thienopyridine therapy (level of evidence 2+; grade of recommendation C).
PATIENT INFORMATION
The patient should be provided with the necessary information for their own health care in a clear, precise and sufficient way. Written informed consent is required when performing invasive diagnostic and therapeutic procedures. The informed consent should include minimum data such as the name, description and objectives of the procedure, general and specific risks, expected benefits and therapeutic alternatives.
In addition, the form should also include details of the identification of the patient and should be signed by the patient or legal representative and the physician. The form should also be dated and include information about the right to accept or refuse the proposed procedure and the right to withdraw consent previously granted (22, 23) .
Since intestinal cleansing is essential to accurately identify a lesion and its margins, patients should be instructed how this is performed according to the latest scientific evidence. Testimony from other patients that have undergone the procedure can be disseminated in order to facilitate the understanding of the procedure and mitigate the patient's fears.
Specific recommendations
-As lesions that are ideal candidates for EMR are often identified during a diagnostic endoscopic procedure, it is recommended that the most important technical considerations of the EMR be included in the general consent for the colonoscopy (level of evidence 4; grade of recommendation D).
-With regard to procedures which the endoscopist expects to be highly complex or associated with a risk of complications, the EMR can be delayed and a specific consent form will be required (level of evidence 4; grade of 13 recommendation D).
-As bowel cleansing is essential to accurately identify the lesion and its margins, correctly. Therefore, it is recommended that the endoscopists involved in performing an EMR meet the highest standards of quality criteria for colonoscopies and that they are fully familiar with the chromoendoscopy techniques (24) . In medium-risk subjects, selective indigo carmine staining is recommended in order to assess the lesions detected with a conventional view. However, panchromoendoscopy is not advised in this situation (25) .
Furthermore, as mentioned in section "Indications", a correct characterization of the lesion is crucial in order to plan the most appropriate treatment. The modified Paris (26) and LST (10, 27) classifications are used for morphological characterization of the lesions. The morphological appearance of the lesion is clearly correlated with the likelihood of an invasive component. In addition, the lesion must also be characterized based on its mucosal pattern and other morphological aspects. In general, the presence of indurated areas, converging folds, ulcers, friability, neovascularization, a columnar appearance, areas of retraction, "goose bumps" around the lesion and depressed areas are highly suggestive of an invasive component (28) . Together, these characteristics are better at predicting submucosal invasion than the non-lifting sign.
Moreover, the mucosal pattern can provide an insight with regard to the existence and depth of the submucosal infiltration and also help differentiate hyperplastic polyps from adenomas. The Kudo's pit pattern is obtained after staining the lesion with a dye 
TECHNICAL ASPECTS
EMR is a routine maneuver used in colonoscopies with varying degrees of difficulty.
Thus, the expertise of the endoscopist plays a crucial role in the efficacy of the procedure. The lesion factors associated with a greater technical difficulty are: location Insufflation with CO 2 instead of ambient air achieves a greater safety profile and an improvement of the patient's tolerance. With regard to electrocautery, the use of currents controlled by a microprocessor (ENDO CUT®) is recommended due to its efficacy and safety profile. Pure cut currents are associated with a greater risk of immediate bleeding, whereas pure coagulation currents are linked to a greater risk of delayed bleeding (36) . For lesions greater than 20 mm, the submucosal injection of substances with a low diffusion rate such as glycerin, gelatin succinate, hyaluronic acid or hydroxypropyl methylcellulose are recommended as they are linked to a greater rate of complete resection. Moreover, it is advisable to include sterile stains such as indigo carmine or methylene blue in the dilution of the submucosal injection as these enable a better delimitation of the lesion margins and the cut plane (37, 38) .
In the case of lesions greater than 20-30 mm, en bloc EMR is not recommended due to the increased risk of perforation and incomplete resection (39) . It is crucial that the EMR be completed in a single session, as the use of more than one session is associated with a greater degree of incomplete resection. The resection should be performed with a diathermy snare, reserving ablative techniques for residual mucosal islets. The post-EMR eschar should be thoroughly reviewed in order to assess the margins and the integrity of the muscle layer (40) . The "underwater" EMR technique is a potential alternative that may be of use when residual lesions on the eschars of previous resections are present (41) . The injection of local anesthetics improves tolerance in resections located near the dentate line (42) . In the case of lesions located behind folds or in the intravalvular part of the ileocecal valve, the use of caps or flexible endoscopes that allow retroflexion is advisable (39) . The use of bands in the colon is not recommended due to the high risk of perforation. Intraoperative bleeding can be controlled with APC, coagulation forceps or the tip of the polypectomy snare set to coagulation mode "soft". If possible, the use of hemostatic clips should be avoided until the resection has been completed (43) .
The recommended tattooing technique for this area consists in inserting the needle tangentially to the mucosa and injecting physiological saline first in order to create a submucosal chamber into which coal and/or Chinese ink is subsequently injected (44) .
Although this technique has been performed routinely and frequently for at least a 
INTRA AND POST-OPERATIVE COMPLICATIONS
The most significant complications related to EMR are bleeding and perforation. These events can be treated and resolved with endoscopic methods in the majority of cases, although surgery may be required in others, especially in the case of a perforation.
Furthermore, complications resulting from the colonoscopy, previous intestinal preparation, sedation and suspension or replacement of the antiplatelet or anticoagulant therapy (when applicable) may also arise. The lack of homogeneous criteria to assess these events and classify them a complication has resulted in a wide variability in the incidence of complications reported in the literature. Moreover, there are few studies that prospectively record all events following the EMR, thus minor complications are probably underestimated.
Bleeding is the most frequent complication related to this procedure, and it usually takes place within the first 48 hours and occasionally up to 14 days later. The incidence of intraoperative bleeding ranges from 3.4% to 24%, 1% to 11% in the case of immediate bleeding and 0% to 9.7% in the case of delayed bleeding. In most cases, the bleeding is self-limited and does not require treatment, with an almost null associated mortality rate. The following characteristics are predisposing factors for a post-EMR bleed: proximal location, large lesion size, intraoperative bleeding, use of electrosurgical units not controlled with a microprocessor, elderly age, high blood pressure and treatment with acetylsalicylic acid or anticoagulants (45) (46) (47) . The use of adrenaline diluted in the submucosal injection is associated with a decreased incidence of early bleeding but does not affect delayed bleeding (48) . Coagulation of visible vessels with argon or coagulation forceps does not reduce the incidence of post-EMR bleeding in the colon or rectum either (49) . In addition, there is no scientific evidence to recommend the systematic closure of eschars with hemostatic clips to prevent post-EMR bleeding. However, the closure of mucosal defects with clips after the EMR of a large lesion in the colon is associated with a reduced risk of delayed bleeding (47) .
The perforation rate is traditionally considered as a quality standard for colonoscopies.
It has a rate of 0.03-0.8% during diagnostic procedures and 0.15-3% during therapeutic
procedures (50). The European Society of Gastrointestinal Endoscopy (ESGE) considers
EMR to have a high risk of perforation, with rates of less than 5% reported for large colon lesions (51, 52) . Risk factors for post-EMR perforation include a large lesion size and location in the right colon. Other factors, such as advanced age, comorbidities, female sex, inflammatory bowel disease, previous abdominal surgeries, indication for a colonoscopy due to an obstruction, sessile morphology (0-Is), fibrosis or deep invasion of the lesion, poor preparation and inexperience of the endoscopist have also been described as risk factors for perforation during a colonoscopy (53) . Early diagnosis is crucial in the management of a perforation and determines the best therapeutic strategy for an optimum patient prognosis. Almost a third of cases are detected immediately and the remaining are detected one to two days after the procedure.
Rarely, cases of delayed perforation are detected 3-14 days after the procedure. After the EMR procedure, it is essential to inspect the mucosal defect and rule out the existence of the so-called target sign. This target sign consists of the presence of tissue from the muscle layer at the base of the resected lesion surrounded by submucosa, and is associated with a high likelihood of damage to the muscle layer itself. In these cases, the eschar should be closed with clips in order to avoid delayed perforation and reduce the need for a subsequent surgery and mortality (3). In the case of perforations measuring less than 2 cm with an acceptable degree of cleansing of the intestinal lumen that occur in clinically and analytically stable patients, these perforations could be treated endoscopically. Surgery is reserved in the event of failure of the endoscopic treatment, for perforations measuring over 2 cm, for cases with a suspicion of sepsis/peritonitis and in patients with a late diagnosis of perforation. In the case of tension pneumoperitoneum, the use of percutaneous decompression maneuvers improves the patient's condition and serves as a bridge therapy until the final treatment to repair the perforation. Broad-spectrum antibiotics must also be added to the endoscopic and surgical treatment regimens (54) . 
EFFICACY AND MONITORING
The estimated global risk of recurrence of a lesion after an EMR is 15% (CI 95% 12- The efficacy of the EMR technique, defined by the absence of signs of recurrence during follow-up, is greater among expert endoscopists than among inexperienced ones. It is important that an endoscopist treats an adequate volume of cases during their training in order to gain sufficient experience in this field. Fortunately, the prevalence of colonic lesions with an indication for EMR is very high. Therefore, the volume of patients is not an issue in Spain (61) .
To the present day, no study has assessed the learning curve in colonic and rectal
EMRs. According to the British Joint Advisory Group (JAG), the recommended number of procedures in order to obtain temporary accreditation for performing colonoscopies is 200 and the number required to obtain full accreditation is 300 procedures. According to the JAG, level 1 polypectomies are focused on polyps measuring less than 1 cm and level 2 polypectomies are used to treat polyps greater than 1 cm. The JAG has also developed a special form for the assessment of skills in EMR via direct observation. The form includes the following items: a) injecting the submucosa correctly using an appropriate injection technique; b) performing the polypectomy only if the lesion is adequately elevated; c) selecting the appropriate snare size; d) directing the snare carefully over the lesion; e) adequately choosing between an en bloc or fragment resection, depending on the size of the lesion; f) placing the snare adequately over the lesion when it is closed; g) ensuring that the correct amount of tissue is taken with the snare; h) carefully separating the lesion from the rest of the healthy mucosa; i) choosing between a cold or diathermy snare correctly; and j) ensuring adequate hemostasis. These forms generate an objective assessment resulting in scores, but they do not provide data on the learning curve of EMRs. After adapting these criteria to the reality of the training in these techniques, the JAG provides a complete certification when an endoscopist has proved sufficient competence in a procedure which allows for an independent practice (62).
In Spain, an adapted and translated scoring system for this purpose is lacking. 
